HK Inno.N Corp banner

Intrinsic Value

The intrinsic value of HK Inno.N Corp (195940) under the Base Case is 53 439.74 KRW per share. Compared with the current market price of 36 250 KRW, the stock appears Undervalued by 32% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩53 439.74
Undervaluation 32%
Intrinsic Value
Price ₩36 250
Alert me when HK Inno.N Corp is below its intrinsic value
Today ₩32 063.84 · 11.5% below the current price

HK Inno.N Corp is cheaper than usual. It was this cheap or cheaper on just 3% of days in the past 5 years.

Alternatives to HK Inno.N Corp

Fundamental Analysis

What HK Inno.N Does

Pharmaceuticals Health Care

HK Inno.N Corp is a South Korean pharmaceutical company that develops, makes, and sells prescription medicines and over-the-counter health products. Its core business is branded drugs for common treatment areas such as digestive health, infections, and other medical conditions, sold through hospitals, clinics, pharmacies, and drug distributors.

Headquarters
Korea KR
Employees
1 695
IPO date
Aug 9, 2021
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
HK Inno.N Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one HK Inno.N Corp stock?

The intrinsic value for HK Inno.N Corp (195940) under the Base Case is 53 439.74 KRW.

Is HK Inno.N Corp stock undervalued or overvalued?

Compared with the current market price of 36 250 KRW, the stock appears Undervalued by 32% .

Back to Top